JP Patent

JP2020536587A — Ｌｄｈａの発現を阻害するための方法及び組成物

Assigned to Dicerna Pharmaceuticals Inc · Expires 2020-12-17 · 5y expired

What this patent protects

本開示は、特に肝細胞においてＬＤＨＡ発現を低減するために有用なオリゴヌクレオチド、組成物及び方法に関する。【選択図】図３

USPTO Abstract

本開示は、特に肝細胞においてＬＤＨＡ発現を低減するために有用なオリゴヌクレオチド、組成物及び方法に関する。【選択図】図３

Drugs covered by this patent

Patent Metadata

Patent number
JP2020536587A
Jurisdiction
JP
Classification
—
Expires
2020-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Dicerna Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.